On Friday, Hims & Hers Health Inc (NYSE: HIMS) opened higher 5.07% from the last session, before settling in for the closing price of $31.54. Price fluctuations for HIMS have ranged from $11.20 to $72.98 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Consumer Defensive Sector giant saw their annual sales surged by 62.28% over the last five years. Company’s average yearly earnings per share was noted 12.05% at the time writing. With a float of $182.04 million, this company’s outstanding shares have now reached $212.46 million.
The firm has a total of 1637 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.65%, operating margin of 4.24%, and the pretax margin is 4.86%.
Hims & Hers Health Inc (HIMS) Insider Activity
A key investor’s attitude towards the stock of the Household & Personal Products industry is another important factor to consider. The insider ownership of Hims & Hers Health Inc is 18.06%, while institutional ownership is 73.63%. The most recent insider transaction that took place on Mar 11 ’25, was worth 76,598. In this transaction PAO of this company sold 2,203 shares at a rate of $34.77, taking the stock ownership to the 2,203 shares. Before that another transaction happened on Mar 11 ’25, when Company’s Officer proposed sale 2,203 for $34.77, making the entire transaction worth $76,598.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.05% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Check out the current performance indicators for Hims & Hers Health Inc (HIMS). In the past quarter, the stock posted a quick ratio of 1.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.99. Likewise, its price to free cash flow for the trailing twelve months is 37.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.53, a number that is poised to hit 0.11 in the next quarter and is forecasted to reach 0.86 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Analysing the last 5-days average volume posted by the [Hims & Hers Health Inc, HIMS], we can find that recorded value of 22.23 million was lower than the volume posted last year of 22.67 million. As of the previous 9 days, the stock’s Stochastic %D was 10.55%. Additionally, its Average True Range was 5.18.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 27.11%, which indicates a significant increase from 13.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 141.27% in the past 14 days, which was higher than the 130.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.74, while its 200-day Moving Average is $25.47. Now, the first resistance to watch is $33.78. This is followed by the second major resistance level at $34.43. The third major resistance level sits at $35.56. If the price goes on to break the first support level at $32.00, it is likely to go to the next support level at $30.87. Should the price break the second support level, the third support level stands at $30.22.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
There are currently 222,166K shares outstanding in the company with a market cap of 7.36 billion. Presently, the company’s annual sales total 1,477 M according to its annual income of 126,040 K. Last quarter, the company’s sales amounted to 481,140 K and its income totaled 26,030 K.
